These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 15485803)

  • 1. [Intensive care and treatment of severe ovarian hyperstimulation syndrome].
    Ma MY; Wen WB; Zhou LX; Yu TO; Fang B
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1212-4. PubMed ID: 15485803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Some aspects of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe ovarian hyperstimulation syndrome: is it really preventable by prophylactic intravenous albumin?
    Ndukwe G; Thornton S; Fishel S; Dowell K; Aloum M
    Fertil Steril; 1997 Nov; 68(5):851-4. PubMed ID: 9389814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive ventilation for the treatment of acute respiratory failure following ovarian hyperstimulation syndrome: report of two cases and a brief review of the literature.
    Barlascini C; Piroddi MG; Perazzo A; Senarega R; Santo M; Nicolini A
    Pneumologia; 2015; 64(2):30-4. PubMed ID: 26506672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrospective analysis of treatment for severe ovary hyperstimulation syndrome complicated by pleural effusion and ascites].
    Gong F; Guo H; Shen Y; Li J; Lu G; Lin G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 37(7):720-4. PubMed ID: 22886212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH.
    van de Lagemaat R; Raafs BC; van Koppen C; Timmers CM; Mulders SM; Hanssen RG
    Endocrinology; 2011 Nov; 152(11):4350-7. PubMed ID: 21896671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and management of ovarian hyperstimulation syndrome.
    Nelson SM
    Thromb Res; 2017 Mar; 151 Suppl 1():S61-S64. PubMed ID: 28262238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RANZCOG CREI Consensus Statement on treatment of Ovarian Hyperstimulation Syndrome.
    Kwik M; Karia S; Boothroyd C
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):413-9. PubMed ID: 26279582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsuspected adverse effect of albumin in severe ovarian hyperstimulation syndrome: a case report.
    Darii N; Pavlovic M; Doroftei B; Emil A
    JBRA Assist Reprod; 2019 Oct; 23(4):430-433. PubMed ID: 31058477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The ovarian hyperstimulation syndrome--diagnostic criteria, management procedures].
    Jakimiuk AJ; Grzybowski W; Zakrzewski J; Lewandowski P; Kozioł K
    Ginekol Pol; 2006 Nov; 77(11):885-92. PubMed ID: 17378130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ovarian hyperstimulation syndrome--a risk of treatment for infertility].
    Bangsbøll S
    Nord Med; 1997 Sep; 112(7):236-9. PubMed ID: 9380489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of ovarian hyperstimulation syndrome.
    Aboulghar M
    Semin Reprod Med; 2010 Nov; 28(6):532-9. PubMed ID: 21082512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian hyperstimulation syndrome and thrombotic events.
    Mor YS; Schenker JG
    Am J Reprod Immunol; 2014 Dec; 72(6):541-8. PubMed ID: 25146913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
    Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
    Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistent hemoconcentration and hypoosmolality during superovulation and in severe ovarian hyperstimulation syndrome: a volume homeostasis paradox.
    Evbuomwan IO; Davison JM; Murdoch AP
    Fertil Steril; 2000 Jul; 74(1):67-72. PubMed ID: 10899499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of ovarian hyperstimulation syndrome. Challenging the estradiol mythos.
    Orvieto R
    Hum Reprod; 2003 Apr; 18(4):665-7. PubMed ID: 12660254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates.
    Atkinson P; Koch J; Ledger WL
    Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):581-5. PubMed ID: 25476811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare manifestations of the ovarian hyperstimulation syndrome: a report of two cases.
    Arikan G; Giuliani A; Gücer F; Auner H; Urdl W
    Clin Exp Obstet Gynecol; 1997; 24(3):154-6. PubMed ID: 9478304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of ovarian hyperstimulation syndrome in the implementation of assisted reproductive technology in women with a background of endocrine pathology.
    Bachmakova NV; Dubrovina OS; Lisovskaya TV; Melkozerova OA; Maysina EN; Sentiurina LB
    Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():25-9. PubMed ID: 25200824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian hyperstimulation syndrome management strategies: where are we going?
    Eskew AM; Omurtag KR
    Minerva Endocrinol; 2018 Mar; 43(1):50-56. PubMed ID: 28322539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.